Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 4/2009

01-08-2009 | Original Article

Blood phenylalanine concentrations in patients with PAH-deficient hyperphenylalaninaemia off diet without and with three different single oral doses of tetrahydrobiopterin: Assessing responsiveness in a model of statistical process control

Authors: M. Lindner, G. Gramer, S. F. Garbade, P. Burgard

Published in: Journal of Inherited Metabolic Disease | Issue 4/2009

Login to get access

Summary

Tetrahydrobiopterin (BH4) cofactor loading is a standard procedure to differentiate defects of BH4 metabolism from phenylalanine hydroxylase (PAH) deficiency. BH4 responsiveness also exists in PAH-deficient patients with high residual PAH activity. Unexpectedly, single cases with presumed nil residual PAH activity have been reported to be BH4 responsive, too. BH4 responsiveness has been defined either by a ≥30% reduction of blood Phe concentration after a single BH4 dose or by a decline greater than the individual circadian Phe level variation. Since both methods have methodological disadvantages, we present a model of statistical process control (SPC) to assess BH4 responsiveness. Phe levels in 17 adult PKU patients of three phenotypic groups off diet were compared without and with three different single oral dosages of BH4 applied in a double-blind randomized cross-over design. Results are compared for ≥30% reduction and SPC. The effect of BH4 by ≥30% reduction was significant for groups (p < 0.01) but not for dose (p = 0.064), with no interaction of group with dose (p = 0.24). SPC revealed significant effects for group (p < 0.01) and the interaction for group with dose (p < 0.05) but not for dose alone (p = 0.87). After one or more loadings, seven patients would be judged to be BH4 responsive either by the 30% criterion or by the SPC model, but only three by both. Results for patients with identical PAH genotype were not very consistent within (for different BH4 doses) and between the two models. We conclude that a comparison of protein loadings without and with BH4 combined with a standardized procedure for data analysis and decision would increase the reliability of diagnostic results.
Literature
go back to reference Gramer G, Garbade SF, Blau N, Lindner M (2009) Pharmacokinetics of tetrahydrobiopterin following oral loadings with three single dosages in patients with phenylketonuria. J Inherit Metab Dis 32(1): 52–57. Epub 2008 Nov 21(in press).PubMedCrossRef Gramer G, Garbade SF, Blau N, Lindner M (2009) Pharmacokinetics of tetrahydrobiopterin following oral loadings with three single dosages in patients with phenylketonuria. J Inherit Metab Dis 32(1): 52–57. Epub 2008 Nov 21(in press).PubMedCrossRef
go back to reference Guldberg P, Rey F, Zschocke J, et al (1998) European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 63: 71–79. doi:10.1086/301920 PubMedCrossRef Guldberg P, Rey F, Zschocke J, et al (1998) European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 63: 71–79. doi:10.​1086/​301920 PubMedCrossRef
go back to reference Güttler F, Azen C, Guldberg P, et al (1999) Relationship among genotype, biochemical phenotype, and cognitive performance in females with phenylalanine hydroxylase deficiency: report from the maternal phenylketonuria collaborative study. Pediatrics 104(2 Pt 1): 258–262. doi:10.1542/peds.104.2.258 PubMedCrossRef Güttler F, Azen C, Guldberg P, et al (1999) Relationship among genotype, biochemical phenotype, and cognitive performance in females with phenylalanine hydroxylase deficiency: report from the maternal phenylketonuria collaborative study. Pediatrics 104(2 Pt 1): 258–262. doi:10.​1542/​peds.​104.​2.​258 PubMedCrossRef
go back to reference Leuzzi V, Carducci C, Carducci C, et al (2006) The spectrum of phenylalanine variations under tetrahydrobiopterin load in subjects affected by phenylalanine hydroxylase deficiency. J Inherit Metab Dis 29: 38–46. doi:10.1007/s10545-006-0096-3 PubMedCrossRef Leuzzi V, Carducci C, Carducci C, et al (2006) The spectrum of phenylalanine variations under tetrahydrobiopterin load in subjects affected by phenylalanine hydroxylase deficiency. J Inherit Metab Dis 29: 38–46. doi:10.​1007/​s10545-006-0096-3 PubMedCrossRef
go back to reference Lindner M, Steinfeld R, Burgard P, Schulze A, Mayatepek E, Zschocke J (2003) Tetrahydrobiopterin sensitivity in German patients with mild phenylalanine hydroxylase deficiency. Hum Mutat 21: 400. doi:10.1002/humu.9117 PubMedCrossRef Lindner M, Steinfeld R, Burgard P, Schulze A, Mayatepek E, Zschocke J (2003) Tetrahydrobiopterin sensitivity in German patients with mild phenylalanine hydroxylase deficiency. Hum Mutat 21: 400. doi:10.​1002/​humu.​9117 PubMedCrossRef
go back to reference Montgomery DG (2005) Introductions to statistical Statistical quality Quality controlControl, 5th edition. New York:John Wiley & Sons, New York. Montgomery DG (2005) Introductions to statistical Statistical quality Quality controlControl, 5th edition. New York:John Wiley & Sons, New York.
go back to reference Schulze A, Lindner M, Kohlmüller D, Olgemöller K, Mayatepek E, Hoffmann GF (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatr Pediatrics 111(6 Pt 1): 1399–406. doi:10.1542/peds.111.6.1399 Schulze A, Lindner M, Kohlmüller D, Olgemöller K, Mayatepek E, Hoffmann GF (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatr Pediatrics 111(6 Pt 1): 1399–406. doi:10.​1542/​peds.​111.​6.​1399
go back to reference Scriver CR, Kaufman S (2001) Hyperphenylalaninemias: phenylalanine hydroxylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1667–1724. Scriver CR, Kaufman S (2001) Hyperphenylalaninemias: phenylalanine hydroxylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1667–1724.
go back to reference Zurflüh MR, Zschocke J, Lindner M, Feillet F, Chery C, Burlina A (2008) Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Hum Mutat 29: 167–75. doi:10.1002/humu.20637 PubMedCrossRef Zurflüh MR, Zschocke J, Lindner M, Feillet F, Chery C, Burlina A (2008) Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Hum Mutat 29: 167–75. doi:10.​1002/​humu.​20637 PubMedCrossRef
Metadata
Title
Blood phenylalanine concentrations in patients with PAH-deficient hyperphenylalaninaemia off diet without and with three different single oral doses of tetrahydrobiopterin: Assessing responsiveness in a model of statistical process control
Authors
M. Lindner
G. Gramer
S. F. Garbade
P. Burgard
Publication date
01-08-2009
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 4/2009
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-009-1070-7

Other articles of this Issue 4/2009

Journal of Inherited Metabolic Disease 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.